Acorn Financial Advisory Services’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,993
Closed -$138K 219
2025
Q4
$138K Sell
11,993
-144
-1% -$2.22K 0.02% 211
2025
Q3
$295K Sell
12,137
-20,478
-63% -$341K 0.05% 160
2025
Q2
$537K Sell
32,615
-1,128
-3% -$19.5K 0.09% 113
2025
Q1
$614K Buy
33,743
+9,162
+37% +$262K 0.11% 90
2024
Q4
$912K Buy
24,581
+8,140
+50% +$311K 0.15% 73
2024
Q3
$526K Buy
16,441
+4,736
+40% +$263K 0.09% 106
2024
Q2
$961K Sell
11,705
-4,859
-29% -$525K 0.18% 69
2024
Q1
$2.4M Buy
16,564
+4,271
+35% +$361K 0.45% 28
2023
Q4
$1.13M Sell
12,293
-1,846
-13% -$188K 0.2% 79
2023
Q3
$2.33M Sell
14,139
-7,398
-34% -$961K 0.42% 30
2023
Q2
$1.36M Sell
21,537
-9,525
-31% -$577K 0.24% 57
2023
Q1
$1.05M Buy
31,062
+4,080
+15% +$213K 0.21% 75
2022
Q4
$1.56M Buy
26,982
+20,908
+344% +$1.29M 0.33% 39
2022
Q3
$571K Buy
6,074
+3,060
+102% +$436K 0.14% 114
2022
Q2
$672K Buy
3,014
+150
+5% +$50.2K 0.16% 90
2022
Q1
$1.57M Buy
2,864
+42
+1% +$25.4K 0.32% 53
2021
Q4
$1.86M Buy
2,822
+830
+42% +$635K 0.37% 43
2021
Q3
$1.67M Buy
1,992
+497
+33% +$504K 0.52% 45
2021
Q2
$1.9M Buy
1,495
+110
+8% +$124K 0.56% 45
2021
Q1
$1.52M Sell
1,385
-29
-2% -$38.3K 0.55% 48
2020
Q4
$2.02M Sell
1,414
-344
-20% -$367K 0.79% 24
2020
Q3
$1.24M Buy
1,758
+57
+3% +$41.4K 0.65% 34
2020
Q2
$1.19M Sell
1,701
-2
-0.1% -$1.16K 0.83% 23
2020
Q1
$595K Buy
+1,703
New +$1.21M 0.59% 53

Other funds holding CDLX

Acorn Financial Advisory Services's CDLX Position: Q1 2026 in Review

Acorn Financial Advisory Services sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 11,993 shares — an estimated $138K sold.

Acorn Financial Advisory Services first reported a position in CDLX in Q1 2020 and held it in 24 quarters. The position peaked at $2.4M in Q1 2024. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Acorn Financial Advisory Services reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
  • Acorn Financial Advisory Services sold 11,993 Cardlytics shares in Q1 2026, an estimated $138K.
  • Acorn Financial Advisory Services first reported a position in Cardlytics in Q1 2020 and held it in 24 quarters.
  • Acorn Financial Advisory Services's Cardlytics position peaked at $2.4M in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Acorn Financial Advisory Services's 13F filing for Q1 2026, filed 24 Apr 2026.